GPX4 and glioblastoma: There have been in vitro studies using TG905 cells showing that the divalent metal transporter 1 (DMT1) and ROS in GBM increases when treated with TMZ, whereas GPX4 is decreased (Su et al., 2022), in the meantime it observes an iron-independent cells death.